Paivi Hartikainen
Overview
Explore the profile of Paivi Hartikainen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
1819
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heikkinen S, Katisko K, Haapasalo A, Portaankorva A, Hartikainen P, Solje E
J Alzheimers Dis
. 2025 Feb;
:13872877251316804.
PMID: 39956963
Background: Differentiating neurodegenerative diseases can be difficult in the clinical setting. This study examines the overlap of diagnostic criteria between frontotemporal dementia (FTD) syndromes with parkinsonism [e.g., corticobasal syndrome (CBS),...
2.
Borroni B, Tarantino B, Graff C, Kruger J, Ludolph A, Moreno F, et al.
Neurology
. 2024 Sep;
103(7):e209793.
PMID: 39226519
Background And Objectives: Data on care home admission and survival rates of patients with syndromes associated with frontotemporal lobar degeneration (FTLD) are limited. However, their estimation is essential to plan...
3.
Kruger J, Aaltonen M, Aho K, Heikkinen S, Kivisild A, Lehtonen A, et al.
Neurology
. 2024 Jul;
103(4):e209654.
PMID: 39047214
Objectives: Current epidemiologic data of early-onset dementia (EOD), characterized by the onset of the disease before the age of 65, are notably scarce. Methods: We evaluated the incidence (from January...
4.
Verkkoniemi-Ahola A, Hartikainen P, Hassi K, Kuusisto H, Lahdenpera S, Mehtala J, et al.
Mult Scler J Exp Transl Clin
. 2023 Oct;
9(4):20552173231204466.
PMID: 37808458
Objectives: The primary objective was to evaluate long-term treatment persistence and safety of natalizumab in Finnish multiple sclerosis patients. The secondary objectives were to assess patient characteristics, use of natalizumab-related...
5.
Periviita V, Palmio J, Jokela M, Hartikainen P, Vihola A, Rauramaa T, et al.
Neurology
. 2023 Sep;
101(18):e1779-e1786.
PMID: 37679049
Background And Objectives: This study aimed to characterize the phenotype of a novel myalgic myopathy encountered in a Finnish family. Methods: Four symptomatic and 3 asymptomatic individuals from 2 generations...
6.
Katisko K, Kruger J, Soppela H, Hartikainen P, Haapasalo A, Remes A, et al.
J Alzheimers Dis
. 2023 Aug;
95(2):677-685.
PMID: 37574738
Background: Due to the significant presence of neuropsychiatric symptoms in patients with frontotemporal dementia (FTD) spectrum disorders, psychiatric misdiagnoses, diagnostic delay, and use of psychiatric treatments are common prior to...
7.
Heikkinen S, Huber N, Katisko K, Kokkola T, Hartikainen P, Kruger J, et al.
J Alzheimers Dis
. 2023 Apr;
93(2):395-401.
PMID: 37038815
Frontotemporal dementia (FTD) can manifest as diverse clinical phenotypes and is frequently caused by mutations in different genes, complicating differential diagnosis. This underlines the urgent need for valid biomarkers. Altered...
8.
Ilmaniemi S, Tolppanen A, Herukka S, Hartikainen P, Hartikainen S
Eur J Neurol
. 2023 Mar;
30(6):1648-1657.
PMID: 36912420
Background And Purpose: Fall-related injuries are a major health concern among people with Parkinson disease (PD). We compared the incidence and postinjury mortality of head injuries and traumatic brain injury...
9.
Logroscino G, Piccininni M, Graff C, Hardiman O, Ludolph A, Moreno F, et al.
JAMA Neurol
. 2023 Jan;
80(3):279-286.
PMID: 36716024
Importance: Diagnostic incidence data for syndromes associated with frontotemporal lobar degeneration (FTLD) in multinational studies are urgent in light of upcoming therapeutic approaches. Objective: To assess the incidence of FTLD...
10.
Soppela H, Kruger J, Hartikainen P, Koivisto A, Haapasalo A, Borroni B, et al.
J Alzheimers Dis
. 2022 Nov;
91(1):225-232.
PMID: 36373318
Background: Currently, there are few studies considering possible modifiable risk factors of frontotemporal dementia (FTD). Objective: In this retrospective case-control study, we evaluated whether a history of traumatic brain injury...